Overview of Short-Term and Long-Term Safety of Brexpiprazole in Patients with Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1875-6441|12|3|278-290

ISSN： 1573-4005

Source： Current Psychiatry Reviews, Vol.12, Iss.3, 2016-12, pp. : 278-290

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of short-term antidepressant treatment on early maladaptive schemas in patients with major depressive and panic disorder

By Atalay Hakan   Atalay Figen   Bağğdaççiççek Sedat  

International Journal of Psychiatry in Clinical Practice, Vol. 15, Iss. 2, 2011-06 ,pp. : 97-105

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Escitalopram in the Long-term Treatment of Major Depressive Disorder

By Wade Alan   Despiegel Nicolas   Heldbo Reines Elin  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 18, Iss. 2, 2006-05 ,pp. : 83-89

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of Adjunctive Brexpiprazole in Patients with Major Depressive Disorder: A Clinical Overview

By  

Current Psychiatry Reviews, Vol. 12, Iss. 3, 2016-12 ,pp. : 291-301

Bentham Science Publishers

Access to resources Recommend Favorite

Long-Term Response to Galantamine in Relation to Short-Term Efficacy Data: Pooled Analysis in Patients with Mild to Moderate Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 8, Iss. 2, 2011-03 ,pp. : 175-186

Bentham Science Publishers

Access to resources Recommend Favorite

Comparison of major depressive disorder and subthreshold depression among older adults in community long-term care

By Lee Mi Jin  

Aging and Mental Health, Vol. 17, Iss. 4, 2013-05 ,pp. : 461-469

Routledge Ltd

Access to resources Recommend Favorite